Lonza Group stock reports 16 percent H1 sales growth

Published on 09/28/2026 at 10:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza Group stock traded at CHF 588.80 on September 28, 2026, with a 0.93 percent daily gain. H1 sales rose 16 percent and margin reached 34.8 percent.

Fotorealistische Reinraum-Bioreaktor-Halle mit glänzenden Edelstahltanks und steriler LED-Beleuchtung — Lonza CH0013841017 zeigt Reinraum Bioreaktor Halle mit Edelstahl Tanks steriler LED Beleuchtung, Illustration mit AI erstellt.

Lonza Group stock (ISIN CH0013841017) was trading at CHF 588.80 on SIX Swiss Exchange on September 28, 2026, with a 0.93 percent daily gain. The latest operating catalyst is Lonza's September 10 plan for a commercial spray-drying facility in Bend, Oregon, a project expected to be completed in 2029 and initially create more than 80 jobs, according to Lonza.

H1 sales reached CHF 3.4 billion

Lonza's first-half 2026 sales reached CHF 3.4 billion, representing 16 percent growth at constant exchange rates from H1 2025. Core EBITDA rose 27.4 percent to CHF 1.2 billion, while the Core EBITDA margin increased 4.4 percentage points to 34.8 percent, according to Yahoo Finance in the July 22, 2026 earnings call transcript.

The cash profile also improved. Free cash flow reached CHF 426 million in H1 2026, compared with CHF 116 million in H1 2025, while capital expenditure fell to 15.7 percent of sales from 21.2 percent, Yahoo Finance reported from the same transcript.

Margin quality now matters

The strongest comparison came from Advanced Synthesis, where H1 sales increased 27.7 percent to CHF 834 million and Core EBITDA margin reached 48.1 percent, up 6.8 percentage points from H1 2025. Management also said that this margin level should normalize in the second half, making the 33 percent to 34 percent full-year margin outlook more important than the peak first-half figure, according to Investing.com on September 16, 2026.

Lonza's full-year outlook calls for 11 percent to 12 percent constant-exchange-rate sales growth and a Core EBITDA margin of 33 percent to 34 percent. The Bend project adds a capacity angle to that outlook, with two spray-drying units planned for a US market where Lonza expects demand for complex drug manufacturing to remain substantial, according to Lonza.

Stock trades near CHF 600

Lonza Group stock was trading at CHF 588.80 on SIX Swiss Exchange on September 28, 2026, with a 0.93 percent daily gain. Its market capitalization stood at CHF 39.3 billion on September 24, 2026, keeping the company's earnings delivery and margin normalization central to the share valuation.